Free Trial
NASDAQ:SPRY

ARS Pharmaceuticals Q2 2024 Earnings Report

ARS Pharmaceuticals logo
$16.78 +0.21 (+1.27%)
Closing price 06/24/2025 04:00 PM Eastern
Extended Trading
$16.93 +0.15 (+0.92%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ARS Pharmaceuticals EPS Results

Actual EPS
-$0.13
Consensus EPS
-$0.12
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

ARS Pharmaceuticals Revenue Results

Actual Revenue
$0.50 million
Expected Revenue
$2.00 million
Beat/Miss
Missed by -$1.50 million
YoY Revenue Growth
N/A

ARS Pharmaceuticals Announcement Details

Quarter
Q2 2024
Time
TAS
Conference Call Date
Tuesday, August 6, 2024
Conference Call Time
4:00PM ET

Upcoming Earnings

ARS Pharmaceuticals' Q2 2025 earnings is scheduled for Tuesday, August 5, 2025, with a conference call scheduled on Wednesday, August 6, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

ARS Pharmaceuticals Earnings Headlines

What is Leerink Partnrs' Estimate for SPRY FY2029 Earnings?
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More ARS Pharmaceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ARS Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ARS Pharmaceuticals and other key companies, straight to your email.

About ARS Pharmaceuticals

ARS Pharmaceuticals (NASDAQ:SPRY), a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

View ARS Pharmaceuticals Profile

More Earnings Resources from MarketBeat